White Paper
Biomol Evidence Alpha White Paper
A technical overview of protected biomolecular evidence workflows for Structural Triage, MD Evidence, and Integrated Evidence Dossier planning.
What the paper covers
Executive summary
Research problem
Platform functions
Protected result model
Evidence bundle model
External NhaA validation
Pilot access model
Integrated Evidence Dossier roadmap
Scope notes
Current validation state
The current paper includes protected result ownership, pilot access, usage counters, Structural Triage, MD Evidence, and the external non-AdK NhaA MD Evidence gate.
Structural Triage
Passed
MD Evidence
Passed
NhaA external gate
Passed
Access protection
Passed